General topological patterns of known drugs

Journal of Molecular Graphics and Modelling

Volumn 20, Issue 1, 2001, Pages 84-94

  Galvez J ^a   De Julian Ortiz J V ^b   Garcia Domenech R ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b J V D J O Investigación de nuevos productos   (Spain)

Author keywords

Compounds; Drugs; Topology

Indexed keywords

DRUG PRODUCTS; GRAPH THEORY; STRUCTURE (COMPOSITION);

PHARMACOLOGICAL ACTIVITY;

TOPOLOGY;

ACETAZOLAMIDE; ACIFRAN; ADRENALIN; ALTRETAMINE; AMILORIDE; AMSACRINE; ATROPINE; BEZAFIBRATE; BUMETANIDE; BUSULFAN; CARBOQUONE; CARMUSTINE; CHLORAMBUCIL; CHLORTALIDONE; CYTARABINE; DACARBAZINE; DRUG; EPHEDRINE; ETACRYNIC ACID; ETOPOSIDE; ETOZOLIN; FENOFIBRATE; FENOPROFEN; FENOTEROL; FENSPIRIDE; FLUOROURACIL; FUROSEMIDE; HALOFENATE; HYDROCHLOROTHIAZIDE; UNINDEXED DRUG;

ARTICLE; CHEMICAL STRUCTURE; DRUG MECHANISM; DRUG RESEARCH; DRUG STRUCTURE; LIBRARY; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL;

DRUG DESIGN; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034784397     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1093-3263(01)00103-6     Document Type: Article

References (33)

1. Exploring QSAR, hydrophobic, electronic, and steric constants
2. Antimicrobial activity characterization in a heterogeneous group of compounds
3. A non-congeneric model for predicting toxicity of organic molecules to Vibrio fischeri
4. Computational ligand design
5. The properties of known drugs. Part 1. Molecular frameworks
6. The properties of known drugs. Part 2. Side chains
7. Identification of biological profiles using substructural analysis and genetic algorithms
8. Indexes of molecular shape from chemical graphs
9. Substructural analysis. A novel approach to the problem of drug design
10. Can we learn to distinguish between "drug-like" and "non-drug-like" molecules?
11. Use of structure-activity data to compare structure-based clustering methods and descriptors for use in compound selection
12. A scoring for discriminating between drugs and non-drugs
13. Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. Part 2. Modeling dispersive and hydrophobic interactions
14. Toward designing drug-like libraries: A novel computational approach for prediction of drug feasibility of compounds
15. Improving the odds in discriminating "drug-like" from "non-drug-like" compounds
16. The design of leadlike combinatorial libraries
17. Property distribution of drug-related chemical databases
18. QSAR using 2D descriptors and TRIPOS' SIMCA
19. Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening
20. Classification of multidrug-resistance reversal agents using structure-based descriptors and linear discriminant analysis
21. Extending the trend vector: The trend matrix and sample-based partial least squares
22. Prediction of the brain-blood distribution of a large set of drugs from structurally derived descriptors using partial least-squares (PLS) modeling
23. Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds
24. Artificial neural network applied to prediction of fluorquinolone antibacterial activity by topological methods
25. A novel approach for the virtual screening and rational design of anticancer compounds
26. QSAR modeling with the electrotopological state indices: Corticosteroids
27. The nature of structure-activity relationships and their relation to molecular connectivity
28. General definition of valence delta-values for molecular connectivity
29. Charge indices. New topological descriptors
30. Topological approach to drug design
31. Structural determination of paraffin boiling points
32. Pharmacological distribution diagrams: A tool for de novo drug design